10月9日，是雪榕转债、领益转债、九洲转2的最后交易日。雪榕转债、领益转债、九洲转2的9月30日收盘价分别为141.55元/张、176.82元/张和124.11元/ 张，如果投资者不及时交易或转股而被强制赎回，可能分别亏损超28%、43%和17%。此前，华友转债部分持有者就因未及时操作导致亏损33%以上。 | < V | | 雪榕转债 | | CO Q | | | --- | --- | --- | --- | --- | --- | | | | 123056 T+0 | | | | | 141.550 37 | | 147.000 最高 | 147.850 最低 | 141.447 | | | 总手 -3.49% -5.114 | | 63596 金额 | 9234万 量比 | | 0.26 | | 昨收 146.664 外盘 | | 28481 内盘 | 35115 | 重零 | | | 正股报价 5.83 -3.16% | | | 转股溢价率 -0.45% > | | | | 分时 五日 | | 日K 周Ｋ | 月Ｋ | 更多, | | | 151.881 | | | 3.56% 卖1 141.550 ...

Core Viewpoint - Xuerong Biological announced a mandatory redemption of its convertible bonds at a price of 100.93 yuan per bond if they are not converted by October 14, 2025, highlighting a significant disparity between the market price and the redemption price, which may lead to substantial investment losses for bondholders [1] Summary by Relevant Sections - **Company Announcement** - Xuerong Biological has issued a notice regarding the mandatory redemption of its convertible bonds, referred to as "Xuerong Convertible Bonds" [1] - The redemption will occur if the bonds are not converted by the specified date, October 14, 2025 [1] - **Market Implications** - There is a notable difference between the current secondary market price of the bonds and the redemption price, which could result in large investment losses for holders if the bonds are forced to be redeemed [1] - The company has specifically warned bondholders to consider converting their bonds before the deadline to avoid potential losses [1]

Core Viewpoint - Xuerong Biological announced that the "Xuerong Convertible Bonds" will be forcibly redeemed if not converted by the close of trading on October 14, 2025, leading to their delisting from the Shenzhen Stock Exchange [1]. Summary by Relevant Sections - **Redemption Announcement** - The company has set a deadline for the conversion of "Xuerong Convertible Bonds" to avoid forced redemption [1]. - **Investor Advisory** - Bondholders are advised to convert their bonds before the deadline to prevent forced redemption, especially if their bonds are pledged or frozen [1].

Group 1 - The article discusses various convertible bonds, including strong redemption announcements and adjustments in terms of bond conditions [2][5] - Specific convertible bonds such as Jingxing Convertible Bond and Chunqiu Convertible Bond are subject to strong redemption, while Gongtong Convertible Bond will not undergo adjustments [5] - The article lists the current prices, redemption prices, last trading dates, and conversion values of several convertible bonds, indicating their market performance and potential investment opportunities [4][7] Group 2 - Shareholders of Zhongtian Rocket plan to reduce their holdings by no more than 3% of the company's shares, while Shennma Co. intends to repurchase shares worth 100 million to 200 million yuan [5] - The article highlights the upcoming subscription for Jin 25 Convertible Bond on September 26 [5] - It provides a detailed table of various convertible bonds, including their current prices, redemption prices, and market capitalization ratios, which can be useful for investors assessing their options [4][7]

Core Viewpoint - Xuerong Bio announced that the "Xuerong Convertible Bonds" will be forcibly redeemed at a price of 100.93 yuan per bond if not converted by October 14, 2025, highlighting a significant disparity between the market price and the redemption price, which may lead to substantial investment losses for bondholders [2] Summary by Relevant Sections - **Company Announcement** - Xuerong Bio has issued a notice regarding the forced redemption of its convertible bonds if they remain unconverted by the specified date [2] - **Market Implications** - The current secondary market price of the "Xuerong Convertible Bonds" is significantly lower than the redemption price, indicating potential financial risks for investors [2] - **Investor Advisory** - The company has specifically warned bondholders to pay attention to the conversion deadline to avoid large investment losses [2]

Core Points - Xuerong Bio announced that the "Xuerong Convertible Bonds" will be forcibly redeemed if not converted by the close of trading on October 14, 2025, after which the bonds will be delisted from the Shenzhen Stock Exchange [2] - Bondholders are advised to convert their bonds within the specified period and to resolve any pledges or freezes on their bonds before the conversion deadline to avoid forced redemption [2]

Group 1 - The core point of the announcement is that the company, Xuerong Biological, will forcibly redeem its convertible bonds ("Xuerong Convertible Bonds") if they are not converted by the close of trading on October 14, 2025, after which these bonds will be delisted from the Shenzhen Stock Exchange [2] - Bondholders are advised to convert their bonds within the specified period to avoid forced redemption [2] - It is recommended that bondholders with pledged or frozen "Xuerong Convertible Bonds"解除质押 or frozen status before the conversion deadline to prevent issues related to redemption [2]

（文章来源：证券日报） 证券日报网讯 9月18日晚间，雪榕生物发布公告称，根据安排，截至2025年10月14日收市后仍未转股 的"雪榕转债"，将按照100.93元/张的价格强制赎回，因目前"雪榕转债"二级市场价格与赎回价格存在较 大差异，若被强制赎回，可能面临大额投资损失，特别提醒"雪榕转债"持有人注意在限期内转股。 ...

（文章来源：证券日报） 证券日报网讯 9月17日晚间，雪榕生物发布公告称，根据安排，截至2025年10月14日收市后仍未转股 的"雪榕转债"将被强制赎回，本次赎回完成后，"雪榕转债"将在深圳证券交易所摘牌。特提醒"雪榕转 债"持有人注意在限期内转股。债券持有人持有的"雪榕转债"如存在被质押或被冻结的，建议在停止转 股日前解除质押或冻结，以免出现因无法转股而被赎回的情形。 ...

（编辑 楚丽君） 证券日报网讯 9月16日晚间，雪榕生物发布公告称，根据安排，截至2025年10月14日收市后仍未转股 的"雪榕转债"将被强制赎回，本次赎回完成后，"雪榕转债"将在深圳证券交易所摘牌。特提醒"雪榕转 债"持有人注意在限期内转股。债券持有人持有的"雪榕转债"如存在被质押或被冻结的，建议在停止转 股日前解除质押或冻结，以免出现因无法转股而被赎回的情形。 ...